Muriel Lemaire
Scientist
Ludwig Center at Brussels
Ludwig Institute for Cancer Research
Belgium
Biography
I am involved in the development of new methods to induce the production of auto-antibodies neutralizing the activities of cytokines in vivo based on DNA vaccination or using cell-based immunization strategies. I also study the cross-regulation of the different T helper subsets, mainly TH1, TH2 and TH17, in inflammatory processes.
Research Interest
Immunology, cellular and molecular biology.
Publications
-
Steenwinckel, Valérie, et al. "IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa." The journal of immunology 182.8 (2009): 4737-4743.
-
Van Belle, Astrid B., et al. "IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice." The Journal of Immunology 188.1 (2012): 462-469.
-
Vekemans, Xavier, et al. "Data from amplified fragment length polymorphism (AFLP) markers show indication of size homoplasy and of a relationship between degree of homoplasy and fragment size." Molecular ecology 11.1 (2002): 139-151.
